Acadia Healthcare (ACHC) Acquires $53M of Quality Addiction Management Stock

Acadia Healthcare (Nasdaq: ACHC) announced that the Company has purchased the stock of Quality Addiction Management (QAM), an operator of seven comprehensive treatment centers in Wisconsin. The transaction is valued at approximately $53 million and is anticipated to be accretive to 2015 earnings by approximately $0.03 to $0.04 per diluted share.

QAM provides behavioral and addiction treatment services to approximately 2,600 patients per day. QAM’s CEO, Dr. Michael S. Goldstone, will join Acadia as Chief Medical Officer for its comprehensive treatment centers.

Joey Jacobs, Chairman and Chief Executive Officer of Acadia, commented, “We believe this transaction is consistent with our growth strategy of acquiring behavioral health services that serve a community need and complement our existing base of services. QAM has a proven track record and long history of providing quality behavioral treatment services, and we look forward to working with QAM’s caring and qualified staff. We also look forward to working with Dr. Goldstone to expand our clinical services and to further enhance the quality of services delivered throughout Acadia’s comprehensive treatment centers.”

You May Also Be Interested In

• American Express (AXP) down despite beating Q1 estimates on top and bottom lines
• Progress Software Corporation (PRGS) Issues Statement on a Possible Offer for MariaDB
• Vail Resorts (MTN) Reports Certain Ski Season Metrics for the Season-to-Date Period Ended April 14